Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Dyne Therapeutics, Inc.
IPO Date: September 17, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $2.43B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.51 | 3.24%
Avg Daily Range (30 D): $0.35 | 2.57%
Avg Daily Range (90 D): $0.34 | 2.87%
Institutional Daily Volume
Avg Daily Volume: .74M
Avg Daily Volume (30 D): 1.93M
Avg Daily Volume (90 D): 2.36M
Trade Size
Avg Trade Size (Sh.): 84
Avg Trade Size (Sh.) (30 D): 86
Avg Trade Size (Sh.) (90 D): 92
Institutional Trades
Total Inst.Trades: 1,916
Avg Inst. Trade: $2.56M
Avg Inst. Trade (30 D): $2.37M
Avg Inst. Trade (90 D): $2.32M
Avg Inst. Trade Volume: .14M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.06M
Avg Closing Trade (30 D): $5.13M
Avg Closing Trade (90 D): $3.83M
Avg Closing Volume: 217.23K
   
News
Sep 29, 2025 @ 12:35 PM
Dyne Therapeutics Receives Orphan Drug Designation...
Source: Globe Newswire
Aug 28, 2025 @ 5:00 PM
Antisense Oligonucleotide Therapeutics Clinical Tr...
Source: Delveinsight
Aug 17, 2025 @ 4:42 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Pomerantz Llp
Aug 9, 2025 @ 4:38 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Danielle Peyton
Jul 14, 2025 @ 2:00 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Pomerantz Llp
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $-3.86 $-.97 $-1.05
Diluted EPS $-3.86 $-.97 $-1.05
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -412.89M $ -110.86M $ -115.36M
Operating Income / Loss $ -440.93M $ -115.79M $ -122.37M
Cost of Revenue $ $ $
Net Cash Flow $ -123.08M $ 12.85M $ 36.81M
PE Ratio